First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort.

Saved in:
Bibliographic Details
Title: First-Line Rituximab in Pediatric-Onset Multiple Sclerosis: Clinical and MRI Outcomes in a Retrospective Cohort.
Authors: Lewis H; Department of Pediatrics, Division of Pediatric Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kiss A; Division of Neurology, Arkansas Children's Hospital, Little Rock, AR, USA., Ramani P; Department of Pediatrics, Division of Pediatric Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Parkey A; Department of Pediatrics, Division of Pediatric Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Haire J; Division of Neurology, Arkansas Children's Hospital, Little Rock, AR, USA., Samanta D; Department of Pediatrics, Division of Pediatric Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Ramakrishnaiah R; Department of Radiology, Division of Pediatric Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Willis E; Department of Pediatrics, Division of Pediatric Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Source: Journal of child neurology [J Child Neurol] 2026 Jun 02, pp. 8830738261452770. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 8606714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-8283 (Electronic) Linking ISSN: 08830738 NLM ISO Abbreviation: J Child Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1708-8283
DOI:10.1177/08830738261452770